Japanese research develops a new method to inhibit renal transplant rejection

Recently, a groundbreaking technique has been developed by researchers from Tokyo Women’s Medical University and Shun Paradise University to prevent the rejection of transplanted organs, specifically in kidney transplantation. This innovative method allows patients to avoid long-term use of immunosuppressive drugs, which are typically required after organ transplants. Not only does this approach eliminate the need for daily medication, but it also avoids the common side effects associated with traditional immunosuppressants. Major Japanese media outlets, including the Yomiuri Shimbun and Asahi Shimbun, have covered this breakthrough. The research focuses on T cells, a type of lymphocyte that plays a central role in the immune system. These cells are responsible for identifying and attacking foreign substances such as viruses, bacteria, and even transplanted organs. In the case of organ transplantation, the body's T cells often recognize the new organ as a threat, leading to a rejection response. If left unchecked, this can result in the failure of the transplanted organ. To address this challenge, Japanese scientists have created a special antibody that "tricks" T cells into not recognizing the transplanted organ as foreign. After extensive testing in animal models, including monkeys, they found that this method effectively suppresses the immune response without compromising the body’s ability to fight infections. The procedure involves collecting T cells from both the patient and the donor before surgery. These cells are then mixed together with the special antibody and incubated for two weeks. The modified T cells are then reintroduced into the patient’s body. Once inside, these cells act as regulators, influencing other T cells and triggering a "misidentification" process. However, unlike traditional immunosuppressants, this method does not impair the immune system’s ability to combat real threats like viruses and bacteria. Previously, transplant recipients had to take immunosuppressive drugs for life, which often led to complications such as kidney damage and chronic rejection. With this new approach, patients only need medication for a short period post-surgery. Once their immune system begins to adjust, the dosage can be gradually reduced and eventually stopped within one to one and a half months. This significantly reduces the risk of long-term side effects. According to the researchers, the success rate of kidney transplants could improve dramatically. They estimate that the percentage of kidneys still functioning after 10 years could rise from 70% to as high as 90%. Beyond kidney transplants, the method is also being explored for use in heart and liver transplants. Given the ongoing challenges with chronic rejection in heart transplants, this development could revolutionize the field of transplant medicine globally. In addition to its medical significance, this advancement highlights the growing importance of personalized immunotherapy in modern medicine. As research continues, it may open the door to more effective and safer treatments for transplant patients worldwide.

Office Digital Safe

Office Safe,Office Digital Safe,Security Office Safe,Electric Key Safe Box

Ningbo Reliance Security Technology CO.,Ltd , https://www.reliancesafes.com